Skip to content

Flexion treats knee osteoarthritis

June 22, 2017

Flexion Therapeutics presents findings from Phase 2 study in patients with knee osteoarthritis and Type 2 diabetes that show Zilretta avoids significant rise in blood glucose seen with an immediate-release corticosteroid. That’s on the Bay State Biotech Report, where Bloomberg biotechnology reporter Doni Bloomfield and Boston radio host Anne Mostue discuss the latest in biotech news from the Boston area and across the nation.

producer: Anne Mostue +1-617-210-4662 or amostue@bloomberg.net.

Running time 01:32

https://player.bloomberg.fm/BLM5711649128?light=true
Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: